Global HER2 Target Drugs Supply, Demand and Key Producers, 2023-2029
The global HER2 Target Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
This report studies the global HER2 Target Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for HER2 Target Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Target Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HER2 Target Drugs total production and demand, 2018-2029, (K Units)
Global HER2 Target Drugs total production value, 2018-2029, (USD Million)
Global HER2 Target Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HER2 Target Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: HER2 Target Drugs domestic production, consumption, key domestic manufacturers and share
Global HER2 Target Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global HER2 Target Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HER2 Target Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global HER2 Target Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda and Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Target Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HER2 Target Drugs Market, By Region:
1. How big is the global HER2 Target Drugs market?
2. What is the demand of the global HER2 Target Drugs market?
3. What is the year over year growth of the global HER2 Target Drugs market?
4. What is the production and production value of the global HER2 Target Drugs market?
5. Who are the key producers in the global HER2 Target Drugs market?
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
This report studies the global HER2 Target Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for HER2 Target Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Target Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HER2 Target Drugs total production and demand, 2018-2029, (K Units)
Global HER2 Target Drugs total production value, 2018-2029, (USD Million)
Global HER2 Target Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HER2 Target Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: HER2 Target Drugs domestic production, consumption, key domestic manufacturers and share
Global HER2 Target Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global HER2 Target Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HER2 Target Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global HER2 Target Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda and Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Target Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HER2 Target Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies
- Small Molecule Chemicals
- Antibody Drug Conjugate
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Other
- Roche
- GSK
- Boehringer Digelheim
- Pfizer
- AstraZeneca
- Seagen
- MacroGenics
- Takeda
- Daiichi Sankyo
- Novartis AG
- RemeGen
- Sunshine Guojian
- Hengrui Medicine
1. How big is the global HER2 Target Drugs market?
2. What is the demand of the global HER2 Target Drugs market?
3. What is the year over year growth of the global HER2 Target Drugs market?
4. What is the production and production value of the global HER2 Target Drugs market?
5. Who are the key producers in the global HER2 Target Drugs market?
1 SUPPLY SUMMARY
1.1 HER2 Target Drugs Introduction
1.2 World HER2 Target Drugs Supply & Forecast
1.2.1 World HER2 Target Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World HER2 Target Drugs Production (2018-2029)
1.2.3 World HER2 Target Drugs Pricing Trends (2018-2029)
1.3 World HER2 Target Drugs Production by Region (Based on Production Site)
1.3.1 World HER2 Target Drugs Production Value by Region (2018-2029)
1.3.2 World HER2 Target Drugs Production by Region (2018-2029)
1.3.3 World HER2 Target Drugs Average Price by Region (2018-2029)
1.3.4 North America HER2 Target Drugs Production (2018-2029)
1.3.5 Europe HER2 Target Drugs Production (2018-2029)
1.3.6 China HER2 Target Drugs Production (2018-2029)
1.3.7 Japan HER2 Target Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HER2 Target Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HER2 Target Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World HER2 Target Drugs Demand (2018-2029)
2.2 World HER2 Target Drugs Consumption by Region
2.2.1 World HER2 Target Drugs Consumption by Region (2018-2023)
2.2.2 World HER2 Target Drugs Consumption Forecast by Region (2024-2029)
2.3 United States HER2 Target Drugs Consumption (2018-2029)
2.4 China HER2 Target Drugs Consumption (2018-2029)
2.5 Europe HER2 Target Drugs Consumption (2018-2029)
2.6 Japan HER2 Target Drugs Consumption (2018-2029)
2.7 South Korea HER2 Target Drugs Consumption (2018-2029)
2.8 ASEAN HER2 Target Drugs Consumption (2018-2029)
2.9 India HER2 Target Drugs Consumption (2018-2029)
3 WORLD HER2 TARGET DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World HER2 Target Drugs Production Value by Manufacturer (2018-2023)
3.2 World HER2 Target Drugs Production by Manufacturer (2018-2023)
3.3 World HER2 Target Drugs Average Price by Manufacturer (2018-2023)
3.4 HER2 Target Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global HER2 Target Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for HER2 Target Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for HER2 Target Drugs in 2022
3.6 HER2 Target Drugs Market: Overall Company Footprint Analysis
3.6.1 HER2 Target Drugs Market: Region Footprint
3.6.2 HER2 Target Drugs Market: Company Product Type Footprint
3.6.3 HER2 Target Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: HER2 Target Drugs Production Value Comparison
4.1.1 United States VS China: HER2 Target Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: HER2 Target Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: HER2 Target Drugs Production Comparison
4.2.1 United States VS China: HER2 Target Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HER2 Target Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: HER2 Target Drugs Consumption Comparison
4.3.1 United States VS China: HER2 Target Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: HER2 Target Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based HER2 Target Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers HER2 Target Drugs Production (2018-2023)
4.5 China Based HER2 Target Drugs Manufacturers and Market Share
4.5.1 China Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers HER2 Target Drugs Production (2018-2023)
4.6 Rest of World Based HER2 Target Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers HER2 Target Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HER2 Target Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Small Molecule Chemicals
5.2.3 Antibody Drug Conjugate
5.3 Market Segment by Type
5.3.1 World HER2 Target Drugs Production by Type (2018-2029)
5.3.2 World HER2 Target Drugs Production Value by Type (2018-2029)
5.3.3 World HER2 Target Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HER2 Target Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Breast Cancer
6.2.2 Colorectal Cancer
6.2.3 Stomach Cancer
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World HER2 Target Drugs Production by Application (2018-2029)
6.3.2 World HER2 Target Drugs Production Value by Application (2018-2029)
6.3.3 World HER2 Target Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche HER2 Target Drugs Product and Services
7.1.4 Roche HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK HER2 Target Drugs Product and Services
7.2.4 GSK HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Boehringer Digelheim
7.3.1 Boehringer Digelheim Details
7.3.2 Boehringer Digelheim Major Business
7.3.3 Boehringer Digelheim HER2 Target Drugs Product and Services
7.3.4 Boehringer Digelheim HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Digelheim Recent Developments/Updates
7.3.6 Boehringer Digelheim Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer HER2 Target Drugs Product and Services
7.4.4 Pfizer HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca HER2 Target Drugs Product and Services
7.5.4 AstraZeneca HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Seagen
7.6.1 Seagen Details
7.6.2 Seagen Major Business
7.6.3 Seagen HER2 Target Drugs Product and Services
7.6.4 Seagen HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Seagen Recent Developments/Updates
7.6.6 Seagen Competitive Strengths & Weaknesses
7.7 MacroGenics
7.7.1 MacroGenics Details
7.7.2 MacroGenics Major Business
7.7.3 MacroGenics HER2 Target Drugs Product and Services
7.7.4 MacroGenics HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MacroGenics Recent Developments/Updates
7.7.6 MacroGenics Competitive Strengths & Weaknesses
7.8 Takeda
7.8.1 Takeda Details
7.8.2 Takeda Major Business
7.8.3 Takeda HER2 Target Drugs Product and Services
7.8.4 Takeda HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Recent Developments/Updates
7.8.6 Takeda Competitive Strengths & Weaknesses
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Details
7.9.2 Daiichi Sankyo Major Business
7.9.3 Daiichi Sankyo HER2 Target Drugs Product and Services
7.9.4 Daiichi Sankyo HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Daiichi Sankyo Recent Developments/Updates
7.9.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.10 Novartis AG
7.10.1 Novartis AG Details
7.10.2 Novartis AG Major Business
7.10.3 Novartis AG HER2 Target Drugs Product and Services
7.10.4 Novartis AG HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis AG Recent Developments/Updates
7.10.6 Novartis AG Competitive Strengths & Weaknesses
7.11 RemeGen
7.11.1 RemeGen Details
7.11.2 RemeGen Major Business
7.11.3 RemeGen HER2 Target Drugs Product and Services
7.11.4 RemeGen HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 RemeGen Recent Developments/Updates
7.11.6 RemeGen Competitive Strengths & Weaknesses
7.12 Sunshine Guojian
7.12.1 Sunshine Guojian Details
7.12.2 Sunshine Guojian Major Business
7.12.3 Sunshine Guojian HER2 Target Drugs Product and Services
7.12.4 Sunshine Guojian HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sunshine Guojian Recent Developments/Updates
7.12.6 Sunshine Guojian Competitive Strengths & Weaknesses
7.13 Hengrui Medicine
7.13.1 Hengrui Medicine Details
7.13.2 Hengrui Medicine Major Business
7.13.3 Hengrui Medicine HER2 Target Drugs Product and Services
7.13.4 Hengrui Medicine HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Hengrui Medicine Recent Developments/Updates
7.13.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HER2 Target Drugs Industry Chain
8.2 HER2 Target Drugs Upstream Analysis
8.2.1 HER2 Target Drugs Core Raw Materials
8.2.2 Main Manufacturers of HER2 Target Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 HER2 Target Drugs Production Mode
8.6 HER2 Target Drugs Procurement Model
8.7 HER2 Target Drugs Industry Sales Model and Sales Channels
8.7.1 HER2 Target Drugs Sales Model
8.7.2 HER2 Target Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 HER2 Target Drugs Introduction
1.2 World HER2 Target Drugs Supply & Forecast
1.2.1 World HER2 Target Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World HER2 Target Drugs Production (2018-2029)
1.2.3 World HER2 Target Drugs Pricing Trends (2018-2029)
1.3 World HER2 Target Drugs Production by Region (Based on Production Site)
1.3.1 World HER2 Target Drugs Production Value by Region (2018-2029)
1.3.2 World HER2 Target Drugs Production by Region (2018-2029)
1.3.3 World HER2 Target Drugs Average Price by Region (2018-2029)
1.3.4 North America HER2 Target Drugs Production (2018-2029)
1.3.5 Europe HER2 Target Drugs Production (2018-2029)
1.3.6 China HER2 Target Drugs Production (2018-2029)
1.3.7 Japan HER2 Target Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HER2 Target Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HER2 Target Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World HER2 Target Drugs Demand (2018-2029)
2.2 World HER2 Target Drugs Consumption by Region
2.2.1 World HER2 Target Drugs Consumption by Region (2018-2023)
2.2.2 World HER2 Target Drugs Consumption Forecast by Region (2024-2029)
2.3 United States HER2 Target Drugs Consumption (2018-2029)
2.4 China HER2 Target Drugs Consumption (2018-2029)
2.5 Europe HER2 Target Drugs Consumption (2018-2029)
2.6 Japan HER2 Target Drugs Consumption (2018-2029)
2.7 South Korea HER2 Target Drugs Consumption (2018-2029)
2.8 ASEAN HER2 Target Drugs Consumption (2018-2029)
2.9 India HER2 Target Drugs Consumption (2018-2029)
3 WORLD HER2 TARGET DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World HER2 Target Drugs Production Value by Manufacturer (2018-2023)
3.2 World HER2 Target Drugs Production by Manufacturer (2018-2023)
3.3 World HER2 Target Drugs Average Price by Manufacturer (2018-2023)
3.4 HER2 Target Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global HER2 Target Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for HER2 Target Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for HER2 Target Drugs in 2022
3.6 HER2 Target Drugs Market: Overall Company Footprint Analysis
3.6.1 HER2 Target Drugs Market: Region Footprint
3.6.2 HER2 Target Drugs Market: Company Product Type Footprint
3.6.3 HER2 Target Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: HER2 Target Drugs Production Value Comparison
4.1.1 United States VS China: HER2 Target Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: HER2 Target Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: HER2 Target Drugs Production Comparison
4.2.1 United States VS China: HER2 Target Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HER2 Target Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: HER2 Target Drugs Consumption Comparison
4.3.1 United States VS China: HER2 Target Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: HER2 Target Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based HER2 Target Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers HER2 Target Drugs Production (2018-2023)
4.5 China Based HER2 Target Drugs Manufacturers and Market Share
4.5.1 China Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers HER2 Target Drugs Production (2018-2023)
4.6 Rest of World Based HER2 Target Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers HER2 Target Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers HER2 Target Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HER2 Target Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Small Molecule Chemicals
5.2.3 Antibody Drug Conjugate
5.3 Market Segment by Type
5.3.1 World HER2 Target Drugs Production by Type (2018-2029)
5.3.2 World HER2 Target Drugs Production Value by Type (2018-2029)
5.3.3 World HER2 Target Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HER2 Target Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Breast Cancer
6.2.2 Colorectal Cancer
6.2.3 Stomach Cancer
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World HER2 Target Drugs Production by Application (2018-2029)
6.3.2 World HER2 Target Drugs Production Value by Application (2018-2029)
6.3.3 World HER2 Target Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche HER2 Target Drugs Product and Services
7.1.4 Roche HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK HER2 Target Drugs Product and Services
7.2.4 GSK HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Boehringer Digelheim
7.3.1 Boehringer Digelheim Details
7.3.2 Boehringer Digelheim Major Business
7.3.3 Boehringer Digelheim HER2 Target Drugs Product and Services
7.3.4 Boehringer Digelheim HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Digelheim Recent Developments/Updates
7.3.6 Boehringer Digelheim Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer HER2 Target Drugs Product and Services
7.4.4 Pfizer HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca HER2 Target Drugs Product and Services
7.5.4 AstraZeneca HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Seagen
7.6.1 Seagen Details
7.6.2 Seagen Major Business
7.6.3 Seagen HER2 Target Drugs Product and Services
7.6.4 Seagen HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Seagen Recent Developments/Updates
7.6.6 Seagen Competitive Strengths & Weaknesses
7.7 MacroGenics
7.7.1 MacroGenics Details
7.7.2 MacroGenics Major Business
7.7.3 MacroGenics HER2 Target Drugs Product and Services
7.7.4 MacroGenics HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MacroGenics Recent Developments/Updates
7.7.6 MacroGenics Competitive Strengths & Weaknesses
7.8 Takeda
7.8.1 Takeda Details
7.8.2 Takeda Major Business
7.8.3 Takeda HER2 Target Drugs Product and Services
7.8.4 Takeda HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Recent Developments/Updates
7.8.6 Takeda Competitive Strengths & Weaknesses
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Details
7.9.2 Daiichi Sankyo Major Business
7.9.3 Daiichi Sankyo HER2 Target Drugs Product and Services
7.9.4 Daiichi Sankyo HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Daiichi Sankyo Recent Developments/Updates
7.9.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.10 Novartis AG
7.10.1 Novartis AG Details
7.10.2 Novartis AG Major Business
7.10.3 Novartis AG HER2 Target Drugs Product and Services
7.10.4 Novartis AG HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis AG Recent Developments/Updates
7.10.6 Novartis AG Competitive Strengths & Weaknesses
7.11 RemeGen
7.11.1 RemeGen Details
7.11.2 RemeGen Major Business
7.11.3 RemeGen HER2 Target Drugs Product and Services
7.11.4 RemeGen HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 RemeGen Recent Developments/Updates
7.11.6 RemeGen Competitive Strengths & Weaknesses
7.12 Sunshine Guojian
7.12.1 Sunshine Guojian Details
7.12.2 Sunshine Guojian Major Business
7.12.3 Sunshine Guojian HER2 Target Drugs Product and Services
7.12.4 Sunshine Guojian HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sunshine Guojian Recent Developments/Updates
7.12.6 Sunshine Guojian Competitive Strengths & Weaknesses
7.13 Hengrui Medicine
7.13.1 Hengrui Medicine Details
7.13.2 Hengrui Medicine Major Business
7.13.3 Hengrui Medicine HER2 Target Drugs Product and Services
7.13.4 Hengrui Medicine HER2 Target Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Hengrui Medicine Recent Developments/Updates
7.13.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HER2 Target Drugs Industry Chain
8.2 HER2 Target Drugs Upstream Analysis
8.2.1 HER2 Target Drugs Core Raw Materials
8.2.2 Main Manufacturers of HER2 Target Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 HER2 Target Drugs Production Mode
8.6 HER2 Target Drugs Procurement Model
8.7 HER2 Target Drugs Industry Sales Model and Sales Channels
8.7.1 HER2 Target Drugs Sales Model
8.7.2 HER2 Target Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World HER2 Target Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World HER2 Target Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World HER2 Target Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World HER2 Target Drugs Production Value Market Share by Region (2018-2023)
Table 5. World HER2 Target Drugs Production Value Market Share by Region (2024-2029)
Table 6. World HER2 Target Drugs Production by Region (2018-2023) & (K Units)
Table 7. World HER2 Target Drugs Production by Region (2024-2029) & (K Units)
Table 8. World HER2 Target Drugs Production Market Share by Region (2018-2023)
Table 9. World HER2 Target Drugs Production Market Share by Region (2024-2029)
Table 10. World HER2 Target Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World HER2 Target Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. HER2 Target Drugs Major Market Trends
Table 13. World HER2 Target Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World HER2 Target Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World HER2 Target Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World HER2 Target Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key HER2 Target Drugs Producers in 2022
Table 18. World HER2 Target Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key HER2 Target Drugs Producers in 2022
Table 20. World HER2 Target Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global HER2 Target Drugs Company Evaluation Quadrant
Table 22. World HER2 Target Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and HER2 Target Drugs Production Site of Key Manufacturer
Table 24. HER2 Target Drugs Market: Company Product Type Footprint
Table 25. HER2 Target Drugs Market: Company Product Application Footprint
Table 26. HER2 Target Drugs Competitive Factors
Table 27. HER2 Target Drugs New Entrant and Capacity Expansion Plans
Table 28. HER2 Target Drugs Mergers & Acquisitions Activity
Table 29. United States VS China HER2 Target Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China HER2 Target Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China HER2 Target Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 37. China Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 47. World HER2 Target Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World HER2 Target Drugs Production by Type (2018-2023) & (K Units)
Table 49. World HER2 Target Drugs Production by Type (2024-2029) & (K Units)
Table 50. World HER2 Target Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World HER2 Target Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World HER2 Target Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World HER2 Target Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World HER2 Target Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World HER2 Target Drugs Production by Application (2018-2023) & (K Units)
Table 56. World HER2 Target Drugs Production by Application (2024-2029) & (K Units)
Table 57. World HER2 Target Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World HER2 Target Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World HER2 Target Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World HER2 Target Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche HER2 Target Drugs Product and Services
Table 64. Roche HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK HER2 Target Drugs Product and Services
Table 70. GSK HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Boehringer Digelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Digelheim Major Business
Table 75. Boehringer Digelheim HER2 Target Drugs Product and Services
Table 76. Boehringer Digelheim HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Boehringer Digelheim Recent Developments/Updates
Table 78. Boehringer Digelheim Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer HER2 Target Drugs Product and Services
Table 82. Pfizer HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca HER2 Target Drugs Product and Services
Table 88. AstraZeneca HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Seagen Basic Information, Manufacturing Base and Competitors
Table 92. Seagen Major Business
Table 93. Seagen HER2 Target Drugs Product and Services
Table 94. Seagen HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Seagen Recent Developments/Updates
Table 96. Seagen Competitive Strengths & Weaknesses
Table 97. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 98. MacroGenics Major Business
Table 99. MacroGenics HER2 Target Drugs Product and Services
Table 100. MacroGenics HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MacroGenics Recent Developments/Updates
Table 102. MacroGenics Competitive Strengths & Weaknesses
Table 103. Takeda Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Major Business
Table 105. Takeda HER2 Target Drugs Product and Services
Table 106. Takeda HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Recent Developments/Updates
Table 108. Takeda Competitive Strengths & Weaknesses
Table 109. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 110. Daiichi Sankyo Major Business
Table 111. Daiichi Sankyo HER2 Target Drugs Product and Services
Table 112. Daiichi Sankyo HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Daiichi Sankyo Recent Developments/Updates
Table 114. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG HER2 Target Drugs Product and Services
Table 118. Novartis AG HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. RemeGen Basic Information, Manufacturing Base and Competitors
Table 122. RemeGen Major Business
Table 123. RemeGen HER2 Target Drugs Product and Services
Table 124. RemeGen HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. RemeGen Recent Developments/Updates
Table 126. RemeGen Competitive Strengths & Weaknesses
Table 127. Sunshine Guojian Basic Information, Manufacturing Base and Competitors
Table 128. Sunshine Guojian Major Business
Table 129. Sunshine Guojian HER2 Target Drugs Product and Services
Table 130. Sunshine Guojian HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sunshine Guojian Recent Developments/Updates
Table 132. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 133. Hengrui Medicine Major Business
Table 134. Hengrui Medicine HER2 Target Drugs Product and Services
Table 135. Hengrui Medicine HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of HER2 Target Drugs Upstream (Raw Materials)
Table 137. HER2 Target Drugs Typical Customers
Table 138. HER2 Target Drugs Typical Distributors
LIST OF FIGURE
Figure 1. HER2 Target Drugs Picture
Figure 2. World HER2 Target Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HER2 Target Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 5. World HER2 Target Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World HER2 Target Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World HER2 Target Drugs Production Market Share by Region (2018-2029)
Figure 8. North America HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 9. Europe HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 10. China HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 11. Japan HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 12. HER2 Target Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 15. World HER2 Target Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 17. China HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 22. India HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of HER2 Target Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for HER2 Target Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for HER2 Target Drugs Markets in 2022
Figure 26. United States VS China: HER2 Target Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: HER2 Target Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HER2 Target Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 30. China Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 32. World HER2 Target Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World HER2 Target Drugs Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies
Figure 35. Small Molecule Chemicals
Figure 36. Antibody Drug Conjugate
Figure 37. World HER2 Target Drugs Production Market Share by Type (2018-2029)
Figure 38. World HER2 Target Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World HER2 Target Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World HER2 Target Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World HER2 Target Drugs Production Value Market Share by Application in 2022
Figure 42. Breast Cancer
Figure 43. Colorectal Cancer
Figure 44. Stomach Cancer
Figure 45. Other
Figure 46. World HER2 Target Drugs Production Market Share by Application (2018-2029)
Figure 47. World HER2 Target Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World HER2 Target Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. HER2 Target Drugs Industry Chain
Figure 50. HER2 Target Drugs Procurement Model
Figure 51. HER2 Target Drugs Sales Model
Figure 52. HER2 Target Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World HER2 Target Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World HER2 Target Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World HER2 Target Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World HER2 Target Drugs Production Value Market Share by Region (2018-2023)
Table 5. World HER2 Target Drugs Production Value Market Share by Region (2024-2029)
Table 6. World HER2 Target Drugs Production by Region (2018-2023) & (K Units)
Table 7. World HER2 Target Drugs Production by Region (2024-2029) & (K Units)
Table 8. World HER2 Target Drugs Production Market Share by Region (2018-2023)
Table 9. World HER2 Target Drugs Production Market Share by Region (2024-2029)
Table 10. World HER2 Target Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World HER2 Target Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. HER2 Target Drugs Major Market Trends
Table 13. World HER2 Target Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World HER2 Target Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World HER2 Target Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World HER2 Target Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key HER2 Target Drugs Producers in 2022
Table 18. World HER2 Target Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key HER2 Target Drugs Producers in 2022
Table 20. World HER2 Target Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global HER2 Target Drugs Company Evaluation Quadrant
Table 22. World HER2 Target Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and HER2 Target Drugs Production Site of Key Manufacturer
Table 24. HER2 Target Drugs Market: Company Product Type Footprint
Table 25. HER2 Target Drugs Market: Company Product Application Footprint
Table 26. HER2 Target Drugs Competitive Factors
Table 27. HER2 Target Drugs New Entrant and Capacity Expansion Plans
Table 28. HER2 Target Drugs Mergers & Acquisitions Activity
Table 29. United States VS China HER2 Target Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China HER2 Target Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China HER2 Target Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 37. China Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based HER2 Target Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers HER2 Target Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers HER2 Target Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers HER2 Target Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers HER2 Target Drugs Production Market Share (2018-2023)
Table 47. World HER2 Target Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World HER2 Target Drugs Production by Type (2018-2023) & (K Units)
Table 49. World HER2 Target Drugs Production by Type (2024-2029) & (K Units)
Table 50. World HER2 Target Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World HER2 Target Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World HER2 Target Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World HER2 Target Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World HER2 Target Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World HER2 Target Drugs Production by Application (2018-2023) & (K Units)
Table 56. World HER2 Target Drugs Production by Application (2024-2029) & (K Units)
Table 57. World HER2 Target Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World HER2 Target Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World HER2 Target Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World HER2 Target Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche HER2 Target Drugs Product and Services
Table 64. Roche HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK HER2 Target Drugs Product and Services
Table 70. GSK HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Boehringer Digelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Digelheim Major Business
Table 75. Boehringer Digelheim HER2 Target Drugs Product and Services
Table 76. Boehringer Digelheim HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Boehringer Digelheim Recent Developments/Updates
Table 78. Boehringer Digelheim Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer HER2 Target Drugs Product and Services
Table 82. Pfizer HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca HER2 Target Drugs Product and Services
Table 88. AstraZeneca HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Seagen Basic Information, Manufacturing Base and Competitors
Table 92. Seagen Major Business
Table 93. Seagen HER2 Target Drugs Product and Services
Table 94. Seagen HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Seagen Recent Developments/Updates
Table 96. Seagen Competitive Strengths & Weaknesses
Table 97. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 98. MacroGenics Major Business
Table 99. MacroGenics HER2 Target Drugs Product and Services
Table 100. MacroGenics HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MacroGenics Recent Developments/Updates
Table 102. MacroGenics Competitive Strengths & Weaknesses
Table 103. Takeda Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Major Business
Table 105. Takeda HER2 Target Drugs Product and Services
Table 106. Takeda HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Recent Developments/Updates
Table 108. Takeda Competitive Strengths & Weaknesses
Table 109. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 110. Daiichi Sankyo Major Business
Table 111. Daiichi Sankyo HER2 Target Drugs Product and Services
Table 112. Daiichi Sankyo HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Daiichi Sankyo Recent Developments/Updates
Table 114. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG HER2 Target Drugs Product and Services
Table 118. Novartis AG HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. RemeGen Basic Information, Manufacturing Base and Competitors
Table 122. RemeGen Major Business
Table 123. RemeGen HER2 Target Drugs Product and Services
Table 124. RemeGen HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. RemeGen Recent Developments/Updates
Table 126. RemeGen Competitive Strengths & Weaknesses
Table 127. Sunshine Guojian Basic Information, Manufacturing Base and Competitors
Table 128. Sunshine Guojian Major Business
Table 129. Sunshine Guojian HER2 Target Drugs Product and Services
Table 130. Sunshine Guojian HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sunshine Guojian Recent Developments/Updates
Table 132. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 133. Hengrui Medicine Major Business
Table 134. Hengrui Medicine HER2 Target Drugs Product and Services
Table 135. Hengrui Medicine HER2 Target Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of HER2 Target Drugs Upstream (Raw Materials)
Table 137. HER2 Target Drugs Typical Customers
Table 138. HER2 Target Drugs Typical Distributors
LIST OF FIGURE
Figure 1. HER2 Target Drugs Picture
Figure 2. World HER2 Target Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HER2 Target Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 5. World HER2 Target Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World HER2 Target Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World HER2 Target Drugs Production Market Share by Region (2018-2029)
Figure 8. North America HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 9. Europe HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 10. China HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 11. Japan HER2 Target Drugs Production (2018-2029) & (K Units)
Figure 12. HER2 Target Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 15. World HER2 Target Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 17. China HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 22. India HER2 Target Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of HER2 Target Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for HER2 Target Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for HER2 Target Drugs Markets in 2022
Figure 26. United States VS China: HER2 Target Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: HER2 Target Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HER2 Target Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 30. China Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers HER2 Target Drugs Production Market Share 2022
Figure 32. World HER2 Target Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World HER2 Target Drugs Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies
Figure 35. Small Molecule Chemicals
Figure 36. Antibody Drug Conjugate
Figure 37. World HER2 Target Drugs Production Market Share by Type (2018-2029)
Figure 38. World HER2 Target Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World HER2 Target Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World HER2 Target Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World HER2 Target Drugs Production Value Market Share by Application in 2022
Figure 42. Breast Cancer
Figure 43. Colorectal Cancer
Figure 44. Stomach Cancer
Figure 45. Other
Figure 46. World HER2 Target Drugs Production Market Share by Application (2018-2029)
Figure 47. World HER2 Target Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World HER2 Target Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. HER2 Target Drugs Industry Chain
Figure 50. HER2 Target Drugs Procurement Model
Figure 51. HER2 Target Drugs Sales Model
Figure 52. HER2 Target Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
